Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Science Matters: A Tantalizing Genomics Tool

This article was originally published in Start Up

Executive Summary

A recent paper in Science demonstrates the power of a chemical genomics-based Connectivity Map to identify the underlying mechanisms--in some cases surprising ones--of experimental drugs. Using this publicly available tool, drug developers may be able to get new information about the potential mechanism of action of the hits coming out of their screens

Related Content

Combining Chemical Genetics and Cancer Immunotherapy
Surmises from Studying DNA Damage: A Link to Type 2 Diabetes?


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts